News and Trends 2 Apr 2025 Top biotech deals of March 2025 …be designed to potentially treat chronic diseases, including rare, autoimmune, and metabolic diseases. Syneron will receive $75 million in upfront and near-term payments as well as development and commercial milestones… April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Jan 2024 Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases? Glucagon-like peptide 1 (GLP-1) agonists have proven their therapeutic mettle in treating metabolic diseases like diabetes and obesity, and now, researchers are studying their effects on cardiovascular disease. These drugs… January 4, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Dec 2023 Nine biotech companies to watch in 2024 …a variety of diseases, including oncology, autoimmune diseases, blood disorders, and fibrosis. Capstan’s technology centers around targeted lipid nanoparticles (tLNPs) for delivering mRNA payloads to cells. This approach aims to… December 19, 2023 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Nov 2023 Eight biotech companies tackling infectious diseases head-on Infectious diseases are diseases that are caused by pathogens that enter the body, hijack the body’s immune system and multiply, causing an infection. Five of the deadliest infectious diseases are… November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Feb 2023 10 biotech companies making a difference in rare diseases …around the world working on and specializing in developing therapies and treatments for people with rare diseases. Research and development involving rare diseases has increased over the past few years,… February 28, 2023 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Apr 2024 Eight biotechnology companies leading the charge in Poland …drugs, and has also secured funding from EU programs aimed at fostering innovation. Celon Pharma’s pipeline includes treatments for drug-resistant unipolar depression and metabolic diseases. The company recently completed the… April 23, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Mar 2025 Nine biotechs thriving in Seattle in 2025 …most effective for cell-based or antibody-based therapies. With the help of this platform, the company aims to identify and treat autoimmune diseases, cancer, infectious diseases, and neurodegenerative diseases. It has… March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2024 Mitochondrial disease treatments: is a breakthrough on the horizon? …properly, it leads to a number of diseases. Various biotechs are now working on treatments to restore mitochondrial function to fight these diseases. One of them is Swiss biopharma Vandria…. September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Jul 2025 Which biotech companies are gaining traction in genetic diseases? …year. Beyond AATD, AIRNA is building a pipeline aimed at both rare and common diseases, some designed to repair damage, others to confer beneficial traits, like enhanced cardiometabolic resilience. Alesta… July 24, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Apr 2025 21 UK biotech companies you should know about …immunotherapies for the treatment of patients with cancer and other diseases. EnteroBiotix Disease area: Inflammatory diseases Technology: Microbial therapies Recent news: Announced positive topline results for lead candidate EBX-102-02 A… April 24, 2025 - 27 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024 From consumer health to pure biopharma: Inside Sanofi’s strategic shift …is a first-in-class antisense oligonucleotide targeting microRNA-22 (miR-22), a non-coding RNA implicated in obesity and related metabolic diseases. By inhibiting miR-22, RES-010 seeks to reprogram metabolic pathways, potentially leading to… November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2025 10 gene therapy companies you should know about …therapeutic programs across a broad range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, cardiovascular diseases, autoimmune diseases, and rare diseases. The company is applying gene editing to treat disease… November 14, 2025 - 15 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email